RYAN MILLOY: Open Payments
NPI 1578013785 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 45 payments from 5 companies in 2025. Trend: 2023 $595 · 2024 $821 · 2025 $797
Food & beverage: $634Education: $163
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $427 |
| ABBVIE INC. | 20 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| Alkermes, Inc. | 1 | $24 |
Products named: UZEDY, VRAYLAR, CAPLYTA, INGREZZA, AUSTEDO XR, LYBALVI.
Industry payments across PA — which companies pay providers there.
